These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6782041)

  • 21. Cost analysis. Self-shielding magnets vs. magnetic room shielding.
    Davis G
    Adm Radiol; 1988 Nov; 7(11):98-102. PubMed ID: 10291086
    [No Abstract]   [Full Text] [Related]  

  • 22. Societal cost of radiation exposure.
    Voillequé PG; Pavlick RA
    Health Phys; 1982 Sep; 43(3):405-9. PubMed ID: 7174334
    [No Abstract]   [Full Text] [Related]  

  • 23. Health risks from ionizing radiation.
    Poppe F
    J Nucl Med Technol; 2003 Sep; 31(3):173; author reply 173. PubMed ID: 12968051
    [No Abstract]   [Full Text] [Related]  

  • 24. Economic Considerations for Radiation Protection in Medical Settings-Is It Time for a New Paradigm?
    Demeter SJ
    Health Phys; 2021 Feb; 120(2):217-223. PubMed ID: 32740141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low attenuation material for table tops, cassettes and grids: a review.
    Hufton AP; Crosthwaite CM; Davies JM; Robinson LA
    Radiography; 1987; 53(607):17-8. PubMed ID: 3104985
    [No Abstract]   [Full Text] [Related]  

  • 26. [Federal Institute for Radiation Protection in critical letter: we cannot clear our work - staff and money affairs].
    Thomasson J
    Vardfacket; 1980 Oct; 4(18):4-5. PubMed ID: 6905590
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-dose extrapolation of radiation health risks: some implications of uncertainty for radiation protection at low doses.
    Land CE
    Health Phys; 2009 Nov; 97(5):407-15. PubMed ID: 19820450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hidden costs of CT bioeffects.
    Lee CI; Forman HP
    J Am Coll Radiol; 2008 Feb; 5(2):78-9. PubMed ID: 18242519
    [No Abstract]   [Full Text] [Related]  

  • 29. Decommissioning activities for NPP A-1 in the Slovak Republic.
    Kristofova K; Rehak I; Vasko M; Daniska V
    Health Phys; 2004 May; 86(5 Suppl):S90-3. PubMed ID: 15069297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SEA's pipe explorer. Science and Engineering Associates.
    Kasper K
    Health Phys; 1998 Oct; 75(4):355-6. PubMed ID: 9753357
    [No Abstract]   [Full Text] [Related]  

  • 31. Using risk assessment, benefit-cost analysis, and real options to implement a precautionary principle.
    Farrow S
    Risk Anal; 2004 Jun; 24(3):727-35. PubMed ID: 15209941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The derivation and application of a risk related value of the spend for saving a statistical life.
    Jackson D; Stone D; Butler GG; McGlynn G
    J Radiol Prot; 2004 Mar; 24(1):41-59. PubMed ID: 15080548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and quality control of radiological methods (author's transl)].
    Wójtowicz J
    Pol Przegl Radiol Med Nukl; 1981; 45(2):115-8. PubMed ID: 6792602
    [No Abstract]   [Full Text] [Related]  

  • 34. [Telediagnosis: from CT availability to diagnostic center?].
    Walz M
    Radiologe; 1997 Apr; 37(4):M50-3. PubMed ID: 9265202
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-cost 7-channel magnetocardiographic system for unshielded environment.
    Budnyk MM; Voytovych ID; Minov YD; Sutkovyi PG; Primin MA; Nedayvoda IV; Vasyliev VV
    Neurol Clin Neurophysiol; 2004 Nov; 2004():112. PubMed ID: 16012647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putting a price on radiation.
    Wood WC
    J Policy Anal Manage; 1983; 2(2):291-5. PubMed ID: 10261065
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T; Pratt WB; Callery MP; Vollmer CM
    J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some nonscientific influences on radiation protection standards and practice. The 1980 Sievert Lecture.
    Taylor LS
    Health Phys; 1980 Dec; 39(6):851-74. PubMed ID: 7204045
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of benefit-to-cost analysis to an X-linked recessive cardiac and humeroperoneal neuromuscular disease.
    Wright ML; Elsas LJ
    Am J Med Genet; 1980; 6(4):315-29. PubMed ID: 6782879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic shielding. Option or necessity?
    Davis GR
    Adm Radiol; 1988 Apr; 7(4):43-4, 46. PubMed ID: 10302448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.